div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documenthmaorgtw-the-control-group-for-seropositive-participants-1-8895-ci-154-231htmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: hmaorgtw · the control group for seropositive participants 1-88%95% CI 154-231 in seropositive controls vs 038% 0-26—054 in seropositive vaccinees and increased by loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsnetreader034viewer20220424035f180af091496b79e1655a71html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documenthmaorgtw-the-control-group-for-seropositive-participants-1-8895-ci-154-231htmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: hmaorgtw · the control group for seropositive participants 1-88%95% CI 154-231 in seropositive controls vs 038% 0-26—054 in seropositive vaccinees and increased by loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsnetreader034viewer20220424035f180af091496b79e1655a71html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documenthmaorgtw-the-control-group-for-seropositive-participants-1-8895-ci-154-231htmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: hmaorgtw · the control group for seropositive participants 1-88%95% CI 154-231 in seropositive controls vs 038% 0-26—054 in seropositive vaccinees and increased by loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader034fdocumentsnetreader034viewer20220424035f180af091496b79e1655a71html5thumbnails3jpg...